Skip to main content
main-content
Erschienen in: Inflammation Research 10-11/2022

15.09.2022 | Original Research Paper

A novel mechanism for inhibiting proliferation of rheumatoid arthritis fibroblast-like synoviocytes: geniposide suppresses HIF-1α accumulation in the hypoxic microenvironment of synovium

verfasst von: Peirong Gan, Minghui Sun, Hong Wu, Jiangtao Ke, Xintong Dong, Fangyuan Chen

Erschienen in: Inflammation Research | Ausgabe 10-11/2022

Einloggen, um Zugang zu erhalten

Abstract

Objective

The excessive proliferation of fibroblast-like synoviocytes (FLSs) is a key inducement for the occurrence and development of rheumatoid arthritis (RA). Hypoxia inducible factor-α (HIF-α) accumulation is involved in the regulation of cell biological functions in the hypoxic microenvironment of synovium. This study aimed to investigate the roles of HIF-α and its level regulator prolyl hydroxylases (PHDs) in FLSs proliferation and to explore the regulatory effect of geniposide (GE).

Materials and methods

Adjuvant arthritis rats and RA-FLSs cell line MH7A were taken as the research objects. MH7A cells were incubated in a hypoxic chamber with 2% O2 for hypoxia treatment. CCK-8, FACS, EdU and Western blot assays were performed to evaluate MH7A cells proliferation. Iron assay was conducted to determine intracellular Fe2+ level.

Results

MH7A cells proliferation was significantly enhanced under hypoxia, accompanied by an increase of HIF-1α level. Decreased HIF-1α level by PX-478 inhibited MH7A cells proliferation. Furthermore, PHD2 was highly expressed in vivo and in vitro, and played a key role in modulation of HIF-1α protein level, which was confirmed by PHD2 inhibitor IOX4 and proteasome inhibitor MG132. GE treatment alleviated synovial hyperplasia in AA rats and inhibited MH7A cells proliferation with a reduction in HIF-1α level. Fe2+ acts as an enzymatic cofactor to control PHD2 activity. Iron assay showed that GE reversed the decline of Fe2+ level in MH7A cells under hypoxia.

Conclusion

GE attenuates abnormal proliferation of RA-FLSs via inhibiting HIF-1α accumulation through enhancement of PHD2 activity.
Literatur
2.
Zurück zum Zitat Rao DA, Gurish MF, Marshall JL, et al. Pathologically expanded peripheral T helper cell subset drives B cells in rheumatoid arthritis. Nature. 2017;542:110–4. CrossRefPubMedPubMedCentral Rao DA, Gurish MF, Marshall JL, et al. Pathologically expanded peripheral T helper cell subset drives B cells in rheumatoid arthritis. Nature. 2017;542:110–4. CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Mankia K, Emery P. Is localized autoimmunity the trigger for rheumatoid arthritis? Unravelling new targets for prevention. Discov Med. 2015;20:129–35. PubMed Mankia K, Emery P. Is localized autoimmunity the trigger for rheumatoid arthritis? Unravelling new targets for prevention. Discov Med. 2015;20:129–35. PubMed
4.
Zurück zum Zitat Ganesan R, Rasool M. Fibroblast-like synoviocytes-dependent effector molecules as a critical mediator for rheumatoid arthritis: current status and future directions. Int Rev Immunol. 2017;36:20–30. CrossRefPubMed Ganesan R, Rasool M. Fibroblast-like synoviocytes-dependent effector molecules as a critical mediator for rheumatoid arthritis: current status and future directions. Int Rev Immunol. 2017;36:20–30. CrossRefPubMed
5.
Zurück zum Zitat Sun W, Ma J, Zhao H, et al. Resolvin D1 suppresses pannus formation via decreasing connective tissue growth factor caused by upregulation of miRNA-146a-5p in rheumatoid arthritis. Arthritis Res Ther. 2020;22:61. CrossRefPubMedPubMedCentral Sun W, Ma J, Zhao H, et al. Resolvin D1 suppresses pannus formation via decreasing connective tissue growth factor caused by upregulation of miRNA-146a-5p in rheumatoid arthritis. Arthritis Res Ther. 2020;22:61. CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Deng W, Feng X, Li X, et al. Hypoxia-inducible factor 1 in autoimmune diseases. Cell Immunol. 2016;303:7–15. CrossRefPubMed Deng W, Feng X, Li X, et al. Hypoxia-inducible factor 1 in autoimmune diseases. Cell Immunol. 2016;303:7–15. CrossRefPubMed
8.
Zurück zum Zitat Watts ER, Walmsley SR. Inflammation and hypoxia: HIF and PHD isoform selectivity. Trends Mol Med. 2019;25:33–46. CrossRefPubMed Watts ER, Walmsley SR. Inflammation and hypoxia: HIF and PHD isoform selectivity. Trends Mol Med. 2019;25:33–46. CrossRefPubMed
9.
Zurück zum Zitat Hu F, Liu H, Xu L, et al. Hypoxia-inducible factor-1α perpetuates synovial fibroblast interactions with T cells and B cells in rheumatoid arthritis. Eur J Immunol. 2016;46:742–51. CrossRefPubMed Hu F, Liu H, Xu L, et al. Hypoxia-inducible factor-1α perpetuates synovial fibroblast interactions with T cells and B cells in rheumatoid arthritis. Eur J Immunol. 2016;46:742–51. CrossRefPubMed
10.
Zurück zum Zitat Ryu JH, Chae CS, Kwak JS, et al. Hypoxia-inducible factor-2α is an essential catabolic regulator of inflammatory rheumatoid arthritis. PLoS Biol. 2014;12: e1001881. CrossRefPubMedPubMedCentral Ryu JH, Chae CS, Kwak JS, et al. Hypoxia-inducible factor-2α is an essential catabolic regulator of inflammatory rheumatoid arthritis. PLoS Biol. 2014;12: e1001881. CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Hu Y, Liu X, Xia Q, et al. Comparative anti-arthritic investigation of iridoid glycosides and crocetin derivatives from gardenia jasminoides ellis in freund’s complete adjuvant-induced arthritis in rats. Phytomedicine. 2019;53:223–33. CrossRefPubMed Hu Y, Liu X, Xia Q, et al. Comparative anti-arthritic investigation of iridoid glycosides and crocetin derivatives from gardenia jasminoides ellis in freund’s complete adjuvant-induced arthritis in rats. Phytomedicine. 2019;53:223–33. CrossRefPubMed
12.
Zurück zum Zitat Shan M, Yu S, Yan H, et al. A review on the phytochemistry, pharmacology, pharmacokinetics and toxicology of geniposide, a natural product. Molecules. 2017;22:1689. CrossRefPubMedCentral Shan M, Yu S, Yan H, et al. A review on the phytochemistry, pharmacology, pharmacokinetics and toxicology of geniposide, a natural product. Molecules. 2017;22:1689. CrossRefPubMedCentral
13.
Zurück zum Zitat Li N, Li L, Wu H, Zhou H. Antioxidative property and molecular mechanisms underlying geniposide-mediated therapeutic effects in diabetes mellitus and cardiovascular disease. Oxid Med Cell Longev. 2019;2019:7480512. PubMedPubMedCentral Li N, Li L, Wu H, Zhou H. Antioxidative property and molecular mechanisms underlying geniposide-mediated therapeutic effects in diabetes mellitus and cardiovascular disease. Oxid Med Cell Longev. 2019;2019:7480512. PubMedPubMedCentral
14.
Zurück zum Zitat Li F, Dai M, Wu H, et al. Immunosuppressive effect of geniposide on mitogen-activated protein kinase signalling pathway and their cross-talk in fibroblast-like synoviocytes of adjuvant arthritis rats. Molecules. 2018;23:91. CrossRefPubMedCentral Li F, Dai M, Wu H, et al. Immunosuppressive effect of geniposide on mitogen-activated protein kinase signalling pathway and their cross-talk in fibroblast-like synoviocytes of adjuvant arthritis rats. Molecules. 2018;23:91. CrossRefPubMedCentral
15.
Zurück zum Zitat Wang RH, Dai XJ, Wu H, et al. Anti-inflammatory effect of geniposide on regulating the functions of rheumatoid arthritis synovial fibroblasts via inhibiting sphingosine-1-phosphate receptors1/3 coupling gαi/gαs conversion. Front Pharm. 2020;11: 584176. CrossRef Wang RH, Dai XJ, Wu H, et al. Anti-inflammatory effect of geniposide on regulating the functions of rheumatoid arthritis synovial fibroblasts via inhibiting sphingosine-1-phosphate receptors1/3 coupling gαi/gαs conversion. Front Pharm. 2020;11: 584176. CrossRef
16.
Zurück zum Zitat Wang Y, Wu H, Deng R, et al. Geniposide downregulates the VEGF/SphK1/S1P pathway and alleviates angiogenesis in rheumatoid arthritis in vivo and in vitro. Phytother Res. 2021;35:4347–62. CrossRefPubMed Wang Y, Wu H, Deng R, et al. Geniposide downregulates the VEGF/SphK1/S1P pathway and alleviates angiogenesis in rheumatoid arthritis in vivo and in vitro. Phytother Res. 2021;35:4347–62. CrossRefPubMed
17.
Zurück zum Zitat Sun M, Deng R, Wang Y, et al. Sphingosine kinase 1/sphingosine 1-phosphate/sphingosine 1-phosphate receptor 1 pathway: a novel target of geniposide to inhibit angiogenesis. Life Sci. 2020;256: 117988. CrossRefPubMed Sun M, Deng R, Wang Y, et al. Sphingosine kinase 1/sphingosine 1-phosphate/sphingosine 1-phosphate receptor 1 pathway: a novel target of geniposide to inhibit angiogenesis. Life Sci. 2020;256: 117988. CrossRefPubMed
18.
Zurück zum Zitat Chen JY, Wu H, Li H, et al. Anti-inflammatory effects and pharmacokinetics study of geniposide on rats with adjuvant arthritis. Int Immunopharmacol. 2015;24:102–9. CrossRefPubMed Chen JY, Wu H, Li H, et al. Anti-inflammatory effects and pharmacokinetics study of geniposide on rats with adjuvant arthritis. Int Immunopharmacol. 2015;24:102–9. CrossRefPubMed
19.
Zurück zum Zitat Dai MM, Wu H, Li H, et al. Effects and mechanisms of geniposide on rats with adjuvant arthritis. Int Immunopharmacol. 2014;20:46–53. CrossRefPubMed Dai MM, Wu H, Li H, et al. Effects and mechanisms of geniposide on rats with adjuvant arthritis. Int Immunopharmacol. 2014;20:46–53. CrossRefPubMed
20.
Zurück zum Zitat Castelli S, Ciccarone F, Tavian D, et al. ROS-dependent HIF1α activation under forced lipid catabolism entails glycolysis and mitophagy as mediators of higher proliferation rate in cervical cancer cells. J Exp Clin Cancer Res. 2021;40:94. CrossRefPubMedPubMedCentral Castelli S, Ciccarone F, Tavian D, et al. ROS-dependent HIF1α activation under forced lipid catabolism entails glycolysis and mitophagy as mediators of higher proliferation rate in cervical cancer cells. J Exp Clin Cancer Res. 2021;40:94. CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Li G, Yang T, Chen Y, et al. USP5 sustains the proliferation of glioblastoma through stabilization of CyclinD1. Front Pharm. 2021;12: 720307. CrossRef Li G, Yang T, Chen Y, et al. USP5 sustains the proliferation of glioblastoma through stabilization of CyclinD1. Front Pharm. 2021;12: 720307. CrossRef
22.
23.
Zurück zum Zitat Bottini N, Firestein GS. Duality of fibroblast-like synoviocytes in RA: passive responders and imprinted aggressors. Nat Rev Rheumatol. 2013;9:24–33. CrossRefPubMed Bottini N, Firestein GS. Duality of fibroblast-like synoviocytes in RA: passive responders and imprinted aggressors. Nat Rev Rheumatol. 2013;9:24–33. CrossRefPubMed
25.
Zurück zum Zitat Liu N, Feng X, Wang W, et al. Paeonol protects against TNF-α-induced proliferation and cytokine release of rheumatoid arthritis fibroblast-like synoviocytes by upregulating FOXO3 through inhibition of miR-155 expression. Inflamm Res. 2017;66:603–10. CrossRefPubMed Liu N, Feng X, Wang W, et al. Paeonol protects against TNF-α-induced proliferation and cytokine release of rheumatoid arthritis fibroblast-like synoviocytes by upregulating FOXO3 through inhibition of miR-155 expression. Inflamm Res. 2017;66:603–10. CrossRefPubMed
26.
Zurück zum Zitat He SD, Huang SG, Zhu HJ, et al. Oridonin suppresses autophagy and survival in rheumatoid arthritis fibroblast-like synoviocytes. Pharm Biol. 2020;58:146–51. CrossRefPubMedPubMedCentral He SD, Huang SG, Zhu HJ, et al. Oridonin suppresses autophagy and survival in rheumatoid arthritis fibroblast-like synoviocytes. Pharm Biol. 2020;58:146–51. CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Chen D, Wu YX, Qiu YB, et al. Hyperoside suppresses hypoxia-induced A549 survival and proliferation through ferrous accumulation via AMPK/HO-1 axis. Phytomedicine. 2020;67: 153138. CrossRefPubMed Chen D, Wu YX, Qiu YB, et al. Hyperoside suppresses hypoxia-induced A549 survival and proliferation through ferrous accumulation via AMPK/HO-1 axis. Phytomedicine. 2020;67: 153138. CrossRefPubMed
28.
Zurück zum Zitat Bahrami A, Atkin SL, Majeed M, et al. Effects of curcumin on hypoxia-inducible factor as a new therapeutic target. Pharm Res. 2018;137:159–69. CrossRef Bahrami A, Atkin SL, Majeed M, et al. Effects of curcumin on hypoxia-inducible factor as a new therapeutic target. Pharm Res. 2018;137:159–69. CrossRef
29.
Zurück zum Zitat Chen J, Cheng W, Li J, et al. Notch-1 and notch-3 mediate hypoxia-induced activation of synovial fibroblasts in rheumatoid arthritis. Arthritis Rheumatol. 2021;73:1810–9. CrossRefPubMed Chen J, Cheng W, Li J, et al. Notch-1 and notch-3 mediate hypoxia-induced activation of synovial fibroblasts in rheumatoid arthritis. Arthritis Rheumatol. 2021;73:1810–9. CrossRefPubMed
30.
Zurück zum Zitat Wohlrab C, Kuiper C, Vissers MC, et al. Ascorbate modulates the hypoxic pathway by increasing intracellular activity of the HIF hydroxylases in renal cell carcinoma cells. Hypoxia (Auckl). 2019;7:17–31. CrossRef Wohlrab C, Kuiper C, Vissers MC, et al. Ascorbate modulates the hypoxic pathway by increasing intracellular activity of the HIF hydroxylases in renal cell carcinoma cells. Hypoxia (Auckl). 2019;7:17–31. CrossRef
31.
Zurück zum Zitat Nguyen TL, Durán RV. Prolyl hydroxylase domain enzymes and their role in cell signaling and cancer metabolism. Int J Biochem Cell Biol. 2016;80:71–80. CrossRefPubMed Nguyen TL, Durán RV. Prolyl hydroxylase domain enzymes and their role in cell signaling and cancer metabolism. Int J Biochem Cell Biol. 2016;80:71–80. CrossRefPubMed
32.
Zurück zum Zitat Wollenick K, Hu J, Kristiansen G, et al. Synthetic transactivation screening reveals ETV4 as broad coactivator of hypoxia-inducible factor signaling. Nucleic Acids Res. 2012;40:1928–43. CrossRefPubMed Wollenick K, Hu J, Kristiansen G, et al. Synthetic transactivation screening reveals ETV4 as broad coactivator of hypoxia-inducible factor signaling. Nucleic Acids Res. 2012;40:1928–43. CrossRefPubMed
33.
Zurück zum Zitat Bagnall J, Leedale J, Taylor SE, et al. Tight control of hypoxia-inducible factor-α transient dynamics is essential for cell survival in hypoxia. J Biol Chem. 2014;289:5549–64. CrossRefPubMedPubMedCentral Bagnall J, Leedale J, Taylor SE, et al. Tight control of hypoxia-inducible factor-α transient dynamics is essential for cell survival in hypoxia. J Biol Chem. 2014;289:5549–64. CrossRefPubMedPubMedCentral
34.
Zurück zum Zitat Henze AT, Riedel J, Diem T, et al. Prolyl hydroxylases 2 and 3 act in gliomas as protective negative feedback regulators of hypoxia-inducible factors. Cancer Res. 2010;70:357–66. CrossRefPubMed Henze AT, Riedel J, Diem T, et al. Prolyl hydroxylases 2 and 3 act in gliomas as protective negative feedback regulators of hypoxia-inducible factors. Cancer Res. 2010;70:357–66. CrossRefPubMed
35.
Zurück zum Zitat Lee SY, Kim HJ, Oh SC, et al. Genipin inhibits the invasion and migration of colon cancer cells by the suppression of HIF-1α accumulation and VEGF expression. Food Chem Toxicol. 2018;116:70–6. CrossRefPubMed Lee SY, Kim HJ, Oh SC, et al. Genipin inhibits the invasion and migration of colon cancer cells by the suppression of HIF-1α accumulation and VEGF expression. Food Chem Toxicol. 2018;116:70–6. CrossRefPubMed
36.
Zurück zum Zitat Tu Y, Li L, Zhu L, et al. Geniposide attenuates hyperglycemia-induced oxidative stress and inflammation by activating the Nrf2 signaling pathway in experimental diabetic retinopathy. Oxid Med Cell Longev. 2021;2021:9247947. CrossRefPubMedPubMedCentral Tu Y, Li L, Zhu L, et al. Geniposide attenuates hyperglycemia-induced oxidative stress and inflammation by activating the Nrf2 signaling pathway in experimental diabetic retinopathy. Oxid Med Cell Longev. 2021;2021:9247947. CrossRefPubMedPubMedCentral
37.
Zurück zum Zitat Park YH, Bae HC, Kim J, et al. Zinc oxide nanoparticles induce HIF-1α protein stabilization through increased reactive oxygen species generation from electron transfer chain complex III of mitochondria. J Dermatol Sci. 2018;91:104–7. CrossRefPubMed Park YH, Bae HC, Kim J, et al. Zinc oxide nanoparticles induce HIF-1α protein stabilization through increased reactive oxygen species generation from electron transfer chain complex III of mitochondria. J Dermatol Sci. 2018;91:104–7. CrossRefPubMed
Metadaten
Titel
A novel mechanism for inhibiting proliferation of rheumatoid arthritis fibroblast-like synoviocytes: geniposide suppresses HIF-1α accumulation in the hypoxic microenvironment of synovium
verfasst von
Peirong Gan
Minghui Sun
Hong Wu
Jiangtao Ke
Xintong Dong
Fangyuan Chen
Publikationsdatum
15.09.2022
Verlag
Springer International Publishing
Erschienen in
Inflammation Research / Ausgabe 10-11/2022
Print ISSN: 1023-3830
Elektronische ISSN: 1420-908X
DOI
https://doi.org/10.1007/s00011-022-01636-5

Weitere Artikel der Ausgabe 10-11/2022

Inflammation Research 10-11/2022 Zur Ausgabe

Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Innere Medizin und bleiben Sie gut informiert – ganz bequem per eMail.